Shenzhen Huainkang Gene Technology Co., Ltd., an earlier independent gene sequencer brand in China, is a biotechnology high-tech group company with gene technology as the core and a complete industrial chain integrating R&D, production and application
Adhering to the concept of "professionalism, rigor, innovation and service", Huayinkang Group has been committed to the health cause of the Chinese nation since its establishment in 2008 and has developed rapidly. So far, it has Shenzhen Huainkang High-throughput Biotechnology Research Institute, Shenzhen Huainkang Gene Technology Co., Ltd., Huainkang Gene Testing Center and many branches across the country, and has become a biotechnology high-tech group with gene technology as the core, strong R&D support, and a complete industrial chain integrating R&D, production and application.
R&D Center – Shenzhen Maincom High Throughput Biotechnology Research Institute has an elite technical team composed of scientists, professors, doctors, postdoctoral fellows and industry experts with cutting-edge technological achievements in mechanical, optical, electronic, biochemical, software, bioinformatics, biomedical and other technical fields. Facing the world's scientific frontiers and national strategic development needs, the institute takes the breakthrough of new DNA sequencing analysis technology as an opportunity to study high-throughput biotechnology, develop high-throughput experimental and testing equipment, find new methods of high-throughput detection, carry out industrial layout for the upstream of China's life science and technology field, build a basic research platform for the life science and technology industry related to gene technology, carry out international cutting-edge genomic science basic and applied research and technology development, and enhance China's independent innovation ability of gene technology.
Product Center-Shenzhen Huayinkang Gene Technology Co., Ltd. specializes in the production and sales of high-throughput gene sequencing equipment, biological reagents and genetic information analysis software, and provides scientific research and technical services and bioinformatics data analysis technical services. The company's leading product, PSTAR high-throughput gene sequencing system, fills the gap in China's core equipment for the life science and technology industry, gene sequencing equipment manufacturing, reagent production and bioinformatics analysis services, and is widely used in basic research of life sciences, clinical diagnosis and treatment, disease prevention and health care, and new drug development.
Relying on the platform technology of Hycon Genomics' next-generation high-throughput gene sequencing system, Gene Testing Center is a professional service organization for translational medicine. The center takes the new generation of high-throughput gene sequencing system technology platform as the core, supplemented by real-time fluorescence PCR platform, STR analysis platform, immunohistochemistry, fluorescence in situ hybridization and other technology platforms, covering DNA, RNA, protein level, sequencing, PCR, protein immunohistochemistry, FISH and other detection technologies. It has taken the lead in developing a variety of clinical genetic testing items suitable for Asians, specializing in providing clinical technical services of "tumor individualized medication guidance target gene testing", and at the same time providing clinical early disease screening, molecular marker testing of major diseases and testing services related to health care and eugenics. We work with top hospitals and scientific research institutions in China to develop a wide range of applications of high-throughput gene sequencing technology in the field of life sciences and medical health, and provide professional and intimate personalized services for human health.
HUAINKANG Genomics (Group) will always adhere to the tenet of "exploring genetic information and improving the value of life", and is committed to building the core competitiveness of Genomics Life Science and Technology in R&D, application and clinical transformation system platform technology, demonstrating the leading position of China's gene industry in the world competition, and leading the new direction of China's health industry development.
